Characteristics of global retractions of schizophrenia-related publications: A bibliometric analysis

Objectives: The growing rate of retraction of scientific publications has attracted much attention within the academic community, but there is little knowledge about the nature of such retractions in schizophrenia-related research. This study aimed to analyze the characteristics of retractions of schizophrenia-related publications.

Materials and methods: The Web of Science was searched for eligible studies. A bibliometric analysis was conducted to describe the characteristics of the retractions using R software and Excel 2019. Content analysis was conducted to examine the essential components of retraction notices.

Results: A total of 36 retracted publications with 415 citations were identified from 1997 to 2021, of which, 83.3% occurred in the last decade. The overall retraction rate was 0.19%, with most of them (29; 80.56%) from the United Kingdom. The retractions were published in 33 journals, and the 2020 IFs ranged between 0.17 and 49.96 (Median = 3.93). The retractions involved 21 research areas, particularly in Psychiatry (19; 52.78%), Neurosciences and Neurology (10; 27.78%), and Psychology (7; 19.44%). Data issues (17; 42.22%), administrative errors of the publishers (5; 13.89%), and study design (4; 11.11%) were the top three reasons for retractions.

Conclusion: This study provides an insight into retractions of schizophrenia-related publications. Institutional governance should be further strengthened to improve the scrutiny of publications, prevent continuing citations, and erroneous propagation after retraction.

Introduction

Retraction of peer-reviewed scientific publications is becoming more common. The growing rate of retractions with the increasing scientific publications in recent years has attracted much attention. Numerous reasons for retractions include concerns about data quality, and research misconduct, such as redundant publication, plagiarism, copyright infringement, unethical research, and peer review manipulation (1). The main objectives of retraction are to ensure research integrity rather than to punish authors, and to alert the academic community that these publications’ findings are not credible and should not be cited (2, 3). In the process of creating innovations, research outputs play a vital role as an important medium for information communication and presentation of findings. The filtering of these publications deserves attention, as the risk of disseminating inaccurate information and results of poor-quality research increases with the rapid expansion of ongoing research (4). For instance, to date, 196 articles related to COVID-19 have been retracted due to various reasons (5). If research articles are fraudulent, they could lead to catastrophic consequences on human health. In 1998, Dr. Andrew Wakefield and his colleagues unethically conducted research on children and concluded that there was a link between measles, mumps, rubella (MMR) vaccine and autism; consequently, thousands of parents refused MMR vaccines for their children which caused an outbreak of fatal measles (6). This misinformation continued to spread for at least 12 years, which had an immeasurable health impact on families with children with autism and also resulted in a huge financial cost to verify the accuracy of this finding (6). Another paper that was retracted from The Lancet due to doubtful data authenticity (7), claimed that hydroxychloroquine was ineffective in treating COVID-19 and even caused arrhythmias, which provoked a strong reaction in the scientific community and the public (8).

The retraction rate of scientific publications across many fields has been increasing in recent years. One study found a retraction rate of 0.38 per 10,000 publications in all fields in 1985, 2.03 in 2000, and 5.95 in 2014 (9), while another study found an average rate of 2.5 per 10,000 between 2013 and 2016 in all fields (10). A recent report found that the retraction rate has increased 10 times in veterinary medicine and animal health publications during the period between 1993 and 2019 (11). The trends of retractions varied by publication year (9) and research field (12, 13). The most common reason for retraction is academic misconduct, such as fraud or suspected fraud, duplicate publications, and plagiarism (13, 14).

Previous studies have reviewed the retracted literature in different specialties of medical fields, such as nursing and midwifery (15), neurosurgery (16), hematology (13), and anesthesiology (1). However, few studies have focused on the mental health literature (17). Schizophrenia is a severe mental disorder characterized by disturbances in perceived reality and behavior, such as persistent delusions, hallucinations, disorganized thinking, negative symptoms, and cognitive impairment (18–20). Approximately 1 in 300 people are affected worldwide, and its global disease burden has increased 11.4% from 1990 to 2019 (21, 22). Beyond the disease itself, relevant stigma and violations of human rights associated with schizophrenia can have a significant impact on the individual’s family, work, and social function (23–25). Additionally, schizophrenia patients have a shorter life expectancy when compared to the general population (18). Due to these features, schizophrenia is one of the most important areas of research in psychiatry and medicine.

A bibliometric analysis showed that the research on schizophrenia has been increasing in recent years, involving a wide range of research areas, including Psychiatry (69.8%), Neurosciences (20.7%), Clinical Neurology (12.4%), Pharmacology and Pharmacy (9.6%), and Genetics/Heredity (3.4%) (26). Schizophrenia related research has mainly focused on epidemiology, etiology, and treatment aspects, but the findings remained variable and at times controversial (18). Ensuring academic rigor is important for the medical advancement in schizophrenia and other fields of medicine. False research results could mislead the academic community or drive researchers in wrong directions, leading to much wasted research resources and negative impact on patient care and recovery (27, 28). Timely retraction is an important measure to prevent erroneous findings from being propagated. However, the nature of retractions in schizophrenia-related publications is unknown.

Bibliometric analysis has been widely used to examine the research trends in a specific field. Compared with traditional descriptive reviews of the literature, it is based on two components: one is the performance analysis that can provide the general characteristics of relevant publications, such as the number of publications, publication years, authors, institutions, countries, and journals; the other is science mapping, which examines and visualizes the relationships between research constituents such as co-citation analysis, bibliographic coupling, co-word and co-authorship analyses. In recent years, bibliometric analysis has been used to explore the characteristics of retractions in academic fields such as rehabilitation (29) and oncology (12). However, to the best of our knowledge, no bibliometric analysis on schizophrenia-related publication retractions has been published. As such, we performed a bibliometric analysis and content analysis of the characteristics of retracted publications on this topic, including publication years, sources, research areas, citations, and reasons for retractions.

Materials and methods

The retracted publications on schizophrenia-related studies were searched from the Web of Science Core Collection in the database of the Web of Science (WoS). The search term was “TI/AB = Schizophrenia OR Schizophrenias OR Schizoaffective OR Schizophreniform OR Psychosis OR Psychotic OR Schizophrenic Disorders OR Disorder, Schizophrenic OR Disorders, Schizophrenic OR Schizophrenic Disorder OR Schizophrenic Disorders OR Dementia Praecox OR Schizoaffective disorder OR Psychotic Disorders.” The article type was limited into “Retracted Publications and Retractions.” A comprehensive screening procedure was conducted manually to avoid false positive or negative results.

The R software and Excel 2019 were used to summarize the characteristics of retractions, including the published year, countries, journals, and research areas. The Journal Impact Factor (IF) in 2020 was used for impact analysis of the journals. Given the rapid growth of journal impact factors, a 5-year IF was used to describe the impact of journals, as it is more stable compared to Immediacy IF. Furthermore, an IF without journal self-citation was used to reduce the potential inflation of IF because self-citation of journals could result in a higher IF value (30). In addition, content analysis was used to examine the reasons for retraction by reviewing the retraction notices. To analyze the transparency of retraction notices, this study included the following four essential components as previously recommended (3): initiators, cause, whether there was consensus between editors and authors on the retraction decisions, and whether retractions were related to the post-publication review (such as comments on PubPeer).

Results

A total of 19,176 publications on schizophrenia-related publications were searched in WoS from its inception to the search date (20/03/2022). Forty retractions were found after limiting the study types, four articles were discarded due to irrelevant topics or duplications in the process of data cleaning. Thirty-six publications from 1997 to 2021 were finally included in this study; of all the retractions, 83.3% (N = 30) occurred in the last decade. The overall retraction rate was 0.19%, and the years of retraction were between 2002 and 2021. The distribution of publication year, retraction year and annual citations are presented in Figure 1. The delay between publication and retraction time (year) ranged from 0 to 10 years with an average of 1.89 years (standard deviation = 2.22 years). The total citations of the 36 retracted publications were 415, with the most citations arising from a single publication (151) (31). The citations of the 36 retractions during the recent ten years accounted for 49.9% (207) of the total citations. Figure 2 presents the distribution of research areas of the retracted publications. The top three included Psychiatry (19, 52.78%), Neurosciences and Neurology (10, 27.78%), and Psychology (7, 19.44%).

FIGURE 1

Figure 1. Distribution of retracted publications on schizophrenia-related studies during 1997 and 2021.

FIGURE 2

Figure 2. Research areas of retracted publications on schizophrenia-related studies.

The retracted publications were from 15 countries or regions. Table 1 shows the top five countries where the publications originated, including the United Kingdom (29; 80.56%), the United States (8; 22.22%), China (8; 22.22%), Canada (7; 19.44%), and Germany (7; 19.44%). Table 2 shows that the 36 retractions were published in 33 different journals. The IFs of the journals (in 2020) ranged between 0.17 and 49.96, with a median of 3.93. The Journal of Developmental and Behavioral Pediatrics (IF = 2.22), Journal of ECT (IF = 3.63), and Psychiatry and Clinical Neurosciences (IF = 5.12) each retracted two publications, respectively. A total of 17 journals (47.2%) were related to Psychology and Psychiatry.

TABLE 1

Table 1. Countries/regions with retractions of schizophrenia-related studies.

TABLE 2

Table 2. Journals with retracted publications on schizophrenia-related studies.

Supplementary Table 1 shows the characteristics of the retractions. All the 36 retraction notices reported the reasons for the retraction. In sum, nine (25.0%) retraction notices did not report who were the initiators, 24 (66.7%) did not report whether there was consensus between editors and authors on the retraction decisions, and 28 (77.8%) did not report whether retractions were related to the post-publication review. Table 3 lists the reasons for retraction as indicated by relevant journals, which include eight categories: data issues (17; 42.22%), administrative errors of the publisher (5; 13.89%), copyright (3; 8.33%), plagiarism (2; 5.56%), redundant publications (2; 5.56%), study design issues (4; 11.11%), ethical issues (1; 2.78%), and others (1, 2.78%). Based on the classification of reasons for paper retraction outlined by the Committee on Publication Ethics (COPE) (2), 11 (30.56%) out of the 36 retracted publications were due to honest errors, including occasional errors made in the original database or experimental data (7; 19.44%) and improper data manipulation (4; 11.11%).

TABLE 3

Table 3. Reasons for retracted publications on schizophrenia-related studies.

Discussion

This is the first bibliometric study on retractions of schizophrenia-related publications. We identified 36 retractions among 19,176 publications on schizophrenia-related studies. The overall retraction rate was relatively lower (0.19%) compared with other fields such as neurosurgery (7.3%) (16). Three-quarters of retractions occurred during the past decade (2011–2021), a trend similar to the retractions in the obstetrics literature where 76% of retractions occurred in the recent decade (2009–2019) (27). This is likely to be related to the overall growing number of academic publications, which may lead to increased academic errors. Additionally, publishers have promoted the awareness of scrutiny of publications (29). Academic misconduct has become a priority in the review procedure for many journals. Currently, many guidelines to standardize the process of retractions are available; of them, the most authoritative guidelines were issued by the COPE (2). The number of retractions has grown since the COPE guidelines were published in 2009 (29). Our analysis revealed that the average gap between publication and retraction time was 1.89 years, which is shorter than the retractions in other fields such as nursing and midwifery (2.3 years) (15) and life science research (3.8 years) (9). A longer delay in retraction may be associated with a more negative academic impact. The erroneous research findings may mislead other researchers, resulting in a waste of time, effort, and resources, and may even harm research participants (27). The high citations of retracted publications suggest that these retractions continued to have a certain impact on the schizophrenia research field as some were still cited even after retraction. Thus, a prompt retraction process is needed and clear signs and labels, such as attaching a clear watermark to the retraction (32), may be helpful in preventing further citations of retracted publications.

The retracted publications identified in this study involved 21 research areas; however, it should be noted that one retracted article may involve more than one research area. More than half of the retractions were classified in the field of Psychiatry (52.78%). The retractions also involved some experiment-based research areas such as Neurosciences, Neurology, Pharmacology, Pharmacy, and Behavioral Sciences. A previous study (29) found that publications based on basic experiments were more likely to be retracted for academic misconduct. Certain countries such as the United Kingdom, United States, China, Canada, and Germany were associated with the most retractions. However, these countries also contributed to the most publications in schizophrenia-related research; the United States contributed the most publications, followed by the United Kingdom, Germany, China, and Canada (26). Most retractions were published in journals related to Psychology/Psychiatry, such as the American Journal of Psychiatry, British Journal of Psychiatry, and Schizophrenia Bulletin. Given the small number of retractions per journal, we could not examine the correlation between the number of retractions and the impact factor of the journals involved. Previous studies on the relationship between retraction rate and journal impact factor found mixed results including positive (33), negative (15), and also non-significant associations (13).

This study analyzed all the retraction notices comprehensively to understand the degree of transparency of retractions. Incomplete information regarding the retraction notices will prevent any assessment of their historical and academic significance, while inadequate information can mislead or distort the readers and provide a biased view (34). Thus, promoting the transparency of the retraction notices is vital to maintain the scientific integrity by acting as a warning or discontinuation measure (35). Although the COPE released a guideline to formalize retraction notices, there has been little or no change to improve the transparency (3). In our study, although the reasons for schizophrenia-related retractions were reported, the other three essential components (e.g., initiators, whether there is consensus between editors and authors on the retraction decision, and whether retractions are related to the post-publication review) were mostly lacking. Possible reasons may include stigma (e.g., fear of reputational damage or legal responsibility), inconsistent requirements regarding the retraction notices between journals (34) and difficulties in implementation. Thus, reform in reporting retractions can encourage authors and publishers to explain the issues clearly and standardize the information provided among journals.

Overall, 86% of retractions of schizophrenia-related studies were attributed to author-related reasons. The most common reason was data issues, of which 64.7% were honest errors. For example, one paper published in Nature (111 citations) entitled “Microglia-dependent synapse loss in type I interferon-mediated lupus” was retracted due to the non-replicable results in the follow-up experiments (36). Another highly-cited paper entitled “Expression of Oct-6, a POUIII domain transcription factor, in schizophrenia” suggested that Oct-6 may be a marker of the neuropathology associated with schizophrenia (37). The data was suspected of being fraudulent; thus, the authenticity of this finding was in doubt. Other studies were retracted due to incomplete data (38), lack of original data (39), or errors in data processing that led to biased conclusions (40). These findings highlight the importance of data accuracy, integrity, and data double-checking.

In contrast, 13.89% of the retractions were due to journal or publisher reasons, such as administrative errors, suggesting publishers should enhance their measures to avoid such errors (16). Three retractions were due to inconsistencies between the contents or research methods and the original study design (41–43). For example, Ninomiya et al. (41) examined the long-term efficacy and safety of blonanserin for first-episode schizophrenia, which was retracted as subjects did not satisfy the inclusion criteria. Incorrect or inappropriate research results could mislead researchers, the public, or even entrepreneurs, resulting in wasted research funds, selection of ineffective drug treatments, and unethical profit-making (4, 44). A study may be invalid or potentially harmful if it does not align with the content of the original study registration. All clinical trials need to be registered before implementation, such as in the International Clinical Trials Registry Platform (ICTRP) supported by the World Health Organization (45). The aim is to ensure adequate knowledge about the research, increase research transparency, and strengthen the validity and value of the scientific evidence base (45).

The lack of ethical governance is another reason for retractions. One paper from the American Journal of Gastroenterology with 151 citations was retracted 10 years after publication; one of the reasons was having no local ethics committee approval (31). Thus, authors, editors and publishers should strengthen the consideration and review of all submitted research information including appropriate ethical approvals. The range and frequency of retraction reasons varied between different academic fields. For example, in both dentistry and obstetrics, redundant publications, and plagiarism were the most common reasons (27, 46), while in the field of pharmacy, falsification, or data manipulation were the most frequent (47), which are in contrast to our findings in schizophrenia-related research. The development and application of Plagiarism Detection software, such as iThenticate and Turnitin (16, 46), may contribute considerably to preventing plagiarism issues. Previous studies have proposed the notion of a “publish or perish” culture to explain the research misconduct issues (1, 9, 48). Quantity and quality of publications are associated with academic ranking, promotion and reputation; further monetary incentives in research commonly occur in some institutions/countries (49). Personality traits combined with highly competitive pressures appear to drive some researchers to falsify or fabricate data (1). Moreover, one study in China found that the majority of survey respondents considered that the current academic assessment system contributes heavily to academic misconduct and needs to be reformed to create a healthy academic environment (50). This supports the importance of developing appropriate academic assessment criteria for researchers. We suggest that the publication of good-quality research is a collaborative effort between organizations, publishers, journals and authors to ensure transparency in reporting, prevent research misconduct and disclose any research limitations.

There are several limitations to this study. First, following relevant guidelines of bibliometric analysis (51) and previous studies (52–54), the WoS was used in the literature search. However, the possibility that some studies may be missed could not be excluded. Second, some retraction notices were conservative in stating the reasons for retraction and the information was limited. For instance, where the study results were not reproducible, it was unclear whether this was due to research misconduct or honest errors. Thus, the retraction notices should be standardized to improve transparency. Third, not all academic misconduct could be uncovered by publishers or readers, therefore retraction rates may well be underestimated.

Conclusion

This study provides an insight into retractions of schizophrenia-related research. The distribution of the retractions varied across countries, journals, and research areas. The number of annual retractions has risen over the past decade with the implementation of existing retraction guidelines, and honest errors account for most retractions. Transparency in reporting retraction notices should be implemented. Researchers should employ measures to ensure the authenticity of their research data. Institutional governance needs to improve the scrutiny of publications and prevent continuing citations and erroneous propagation after retraction.

Data availability statement

The original contributions presented in this study are included in the article/Supplementary material, further inquiries can be directed to the corresponding authors.

Author contributions

PC and Y-TX: study design. PC, X-HL, ZS, YM, and Y-TX: data collection, analysis, and interpretation. PC, Y-LT, and Y-TX: drafting of the manuscript. CN: critical revision of the manuscript. All authors approval of the final version for publication.

Funding

This study was supported by the Beijing Municipal Science and Technology Commission (Grant No. Z181100001718124), Beijing Talents Foundation (Grant No. 2017000021469G222), the University of Macau (MYRG2019-00066-FHS), Scientific Research Common Program of Beijing Municipal Commission of Education (KM202010025011), and Beijing Municipal Science and Tech Commission (Z191100006619061).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fpsyt.2022.937330/full#supplementary-material

References

1. Nair S, Yean C, Yoo J, Leff J, Delphin E, Adams DC. Reasons for article retraction in anesthesiology: a comprehensive analysis. Can J Anaesth. (2020) 67:57–63. doi: 10.1007/s12630-019-01508-3

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Committee on Publication Ethics. Guidelines: Retraction Guidelines. (2019). Available online at: https://publicationethics.org/guidance (accessed March 22, 2022).

Google Scholar

3. Vuong Q-H. Reform retractions to make them more transparent. Nature. (2020) 582:149. doi: 10.1038/d41586-020-01694-x

CrossRef Full Text | Google Scholar

4. Vuong Q-H, Le T-T, La V-P, Nguyen HTT, Ho M-T, Van Khuc Q, et al. Covid-19 vaccines production and societal immunization under the serendipity-mindsponge-3d knowledge management theory and conceptual framework. Hum Soc Sci Commu. (2022) 9:22. doi: 10.1057/s41599-022-01034-6

CrossRef Full Text | Google Scholar

5. Khan H, Gupta P, Zimba O, Gupta L. Bibliometric and altmetric analysis of retracted articles on Covid-19. JKMS. (2022) 37:e44. doi: 10.3346/jkms.2022.37.e44

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Eggertson L. Lancet retracts 12-year-old article linking autism to Mmr vaccines. CMAJ. (2010) 182:E199–200. doi: 10.1503/cmaj.109-3179

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Mehra MR, Ruschitzka F, Patel AN. Retraction: hydroxychloroquine or chloroquine with or without a macrolide for treatment of Covid-19: a multinational registry analysis. Lancet. (2020) 395:1820. doi: 10.1016/S0140-6736(20)31324-6

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Ledford H, Van Noorden R. High-profile coronavirus retractions raise concerns about data oversight. Nature. (2020) 582:160. doi: 10.1038/d41586-020-01695-w

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Bhatt BA. Multi-perspective analysis of retractions in life sciences. Scientometrics. (2021) 126:4039–54. doi: 10.1007/s11192-021-03907-0

CrossRef Full Text | Google Scholar

10. Campos-Varela I, Ruano-Raviña A. Misconduct as the main cause for retraction. a descriptive study of retracted publications and their authors. Gac Sanit. (2019) 33:356–60. doi: 10.1016/j.gaceta.2018.01.009

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Christopher MM. Comprehensive analysis of retracted journal articles in the field of veterinary medicine and animal health. BMC Vet Res. (2022) 18:73. doi: 10.1186/s12917-022-03167-x

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Pantziarka P, Meheus L. Journal retractions in oncology: a bibliometric study. Future Oncol. (2019) 15:3597–608. doi: 10.2217/fon-2019-0233

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Panahi S, Soleimanpour S. The landscape of the characteristics, citations, scientific, technological, and altmetrics impacts of retracted papers in hematology. Accoun Res. (2021):1–16. doi: 10.1080/08989621.2021.1990049

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Fang FC, Steen RG, Casadevall A. Misconduct accounts for the majority of retracted scientific publications. Proc Natl Acad Sci USA. (2012) 109:17028–33. doi: 10.1073/pnas.1212247109

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Al-Ghareeb A, Hillel S, McKenna L, Cleary M, Visentin D, Jones M, et al. Retraction of publications in nursing and midwifery research: a systematic review. Int J Nurs Stud. (2018) 81:8–13. doi: 10.1016/j.ijnurstu.2018.01.013

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Wang J, Ku JC, Alotaibi NM, Rutka JT. Retraction of neurosurgical publications: a systematic review. World Neurosurg. (2017) 103:809.e–14.e. doi: 10.1016/j.wneu.2017.04.014

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Bakker C, Riegelman A. Retracted publications in mental health literature: discovery across bibliographic platforms. J Libra Sch Commun. (2018) 6:e2199.

Google Scholar

18. World Health Organization. Schizophrenia. (2022). Available online at: https://www.who.int/news-room/fact-sheets/detail/schizophrenia (accessed June 7, 2022)

Google Scholar

19. Yeo JJ, Chew QH, Sim K. Resilience and its inter-relationship with symptomatology, illness course, psychosocial functioning, and mediational roles in schizophrenia: a systematic review. Asia Pac Psychiatry. (2022) 14:e12486. doi: 10.1111/appy.12486

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Hartopo D, Kalalo RT. Language disorder as a marker for schizophrenia. Asia Pac Psychiatry. (2021):e12485. doi: 10.1111/appy.12485

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Haro JM, McGrath JJ. The burden of schizophrenia. Eur Neuropsychopharmacol. (2022) 57:33–5. doi: 10.1016/j.euroneuro.2021.12.009

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. Lancet. (2022) 399:473–86. doi: 10.1016/S0140-6736(21)01730-X

CrossRef Full Text | Google Scholar

23. Mueser KT, McGurk SR. Schizophrenia. Lancet. (2004) 363:2063–72. doi: 10.1016/S0140-6736(04)16458-1

CrossRef Full Text | Google Scholar

24. Lin C-H, Lai T-Y, Chen Y-J, Lin S-K. Social distance towards schizophrenia in health professionals. Asia Pac Psychiatry. (2021):e12506. doi: 10.1111/appy.12506

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Khatimah CH, Adami A, Abdullah A, Marthoenis. Quality of life, mental health, and family functioning of schizophrenia caregivers: a community-based cross-sectional study. Asia Pac Psychiatry. (2022) 14:e12467. doi: 10.1111/appy.12467

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Kiraz S, Demir E. Global scientific outputs of schizophrenia publications from 1975 to 2020: a bibliometric analysis. Psychiatr Q. (2021) 92:1725–44. doi: 10.1007/s11126-021-09937-4

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Bennett C, Chambers LM, Al-Hafez L, Michener CM, Falcone T, Yao M, et al. Retracted articles in the obstetrics literature: lessons from the past to change the future. Am J Obstetr Gynecol MFM. (2020) 2:100201. doi: 10.1016/j.ajogmf.2020.100201

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Sher L, Kahn RS. Suicide in schizophrenia: an educational overview. Medicina (Kaunas). (2019) 55:361. doi: 10.3390/medicina55070361

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Bordino M, Ravizzotti E, Vercelli S. Retracted articles in rehabilitation: just the tip of the iceberg? A bibliometric analysis. Arch Physiother. (2020) 10:21. doi: 10.1186/s40945-020-00092-w

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Opthof T. Inflation of impact factors by journal self-citation in cardiovascular science. Neth Heart J. (2013) 21:163–5. doi: 10.1007/s12471-013-0384-0

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Wakefield AJ, Anthony A, Murch SH, Thomson M, Montgomery SM, Davies S, et al. Retracted: enterocolitis in children with developmental disorders. Am J Gastroenterol. (2000) 95:2285–95.

Google Scholar

32. Mena JD, Ndoye M, Cohen AJ, Kamal P, Breyer BN. The landscape of urological retractions: the prevalence of reported research misconduct. BJU Int. (2019) 124:174–9. doi: 10.1111/bju.14706

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Fang FC, Casadevall A. Retracted science and the retraction index. Infect Immun. (2011) 79:3855–9. doi: 10.1128/iai.05661-11

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Teixeira da Silva JA, Vuong Q-H. Fortification of retraction notices to improve their transparency and usefulness. Learn Publish. (2022) 35:292–9. doi: 10.1002/leap.1409

CrossRef Full Text | Google Scholar

35. Drimer-Batca D, Iaccarino JM, Fine A. Status of retraction notices for biomedical publications associated with research misconduct. Res Ethics. (2019) 15:1–5. doi: 10.1177/1747016118820496

CrossRef Full Text | Google Scholar

36. Bialas AR, Presumey J, Das A, van der Poel CE, Lapchak PH, Mesin L, et al. Retracted: microglia-dependent synapse loss in type I interferon-mediated lupus. Nature. (2020) 578:177. doi: 10.1038/s41586-020-1949-x

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Ilia M, Beasley C, Meijer D, Kerwin R, Cotter D, Everall I, et al. Expression of Oct-6, a Pouiii domain transcription factor, in schizophrenia. Am J Psychiatry. (2002) 159:1174–82. doi: 10.1176/appi.ajp.159.7.1174

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Yang H, Li JJ, Ji AC, Hu LP, Zhang XF, Liu LL, et al. Methylation of the maoa promoter is associated with schizophrenia. Ann Transl Med. (2020) 8:864. doi: 10.21037/atm-2020-42

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Ren ZB, Wang HQ, Feng B, Gu CY, Ma YC, Chen H, et al. A cross-sectional study on perception of stigma by Chinese schizophrenia patients. Neuropsychiatr Dis Treat. (2014) 10:535–40. doi: 10.2147/ndt.S54115

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Inoshita M, Numata S, Tajima A, Kinoshita M, Umehara H, Nakataki M, et al. A significant causal association between c-reactive protein levels and schizophrenia. Sci Rep. (2018) 8:46947. doi: 10.1038/srep46947

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Ninomiya Y, Miyamoto S, Tenjin T, Ogino S, Miyake N, Kaneda Y, et al. Retracted: long-term efficacy and safety of blonanserin in patients with first-episode schizophrenia: a 1-year open-label trial. Psychiatry Clin Neurosci. (2014) 68:841–9. doi: 10.1111/pcn.12202

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Tenjin T, Miyamoto S, Miyake N, Ogino S, Kitajima R, Ojima K, et al. Retraction: effect of blonanserin on cognitive function in antipsychotic-naive first-episode schizophrenia. Hum Psychopharmacol Clin Exp. (2012) 27:90–100. doi: 10.1002/hup.2622

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Guo ZH, Li ZJ, Ma Y, Sun J, Guo JH, Li WX, et al. Retraction: brief cognitive-behavioural therapy for patients in the community with schizophrenia: randomised controlled trial in Beijing, China. Br J Psychiatry. (2019) 215:435. doi: 10.1192/bjp.2019.91

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Vuong Q-H. The (Ir)rational consideration of the cost of science in transition economies. Nat Hum Behav. (2018) 2:5. doi: 10.1038/s41562-017-0281-4

PubMed Abstract | CrossRef Full Text | Google Scholar

45. World Health Organization. International Standards for Clinical Trial Registries. (2018). Available online at: https://www.who.int/publications/i/item/international-standards-for-clinical-trial-registers (accessed March 26, 2022)

Google Scholar

46. Nogueira TE, Gonçalves AS, Leles CR, Batista AC, Costa LRA. Survey of retracted articles in dentistry. BMC Res Notes. (2017) 10:253. doi: 10.1186/s13104-017-2576-y

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Brown SJ, Bakker CJ, Theis-Mahon NR. Retracted publications in pharmacy systematic reviews. J Med Libr Assoc. (2022) 110:47–55. doi: 10.5195/jmla.2022.1280

PubMed Abstract | CrossRef Full Text | Google Scholar

48. Neill US. Publish or perish, but at what cost? J Clin Invest. (2008) 118:2368. doi: 10.1172/jci36371

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Wang T, Xing QR, Wang H, Chen W. Retracted publications in the biomedical literature from open access journals. Sci Eng Ethics. (2019) 25:855–68. doi: 10.1007/s11948-018-0040-6

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Liao Q-J, Zhang Y-Y, Fan Y-C, Zheng M-H, Bai Y, Eslick GD, et al. Perceptions of Chinese biomedical researchers towards academic misconduct: a comparison between 2015 and 2010. Sci Eng Ethics. (2018) 24:629–45. doi: 10.1007/s11948-017-9913-3

PubMed Abstract | CrossRef Full Text | Google Scholar

51. Donthu N, Kumar S, Mukherjee D, Pandey N, Lim WM. How to conduct a bibliometric analysis: an overview and guidelines. J Bus Res. (2021) 133:285–96. doi: 10.1016/j.jbusres.2021.04.070

CrossRef Full Text | Google Scholar

52. Chen Y, Zhang X, Chen S, Zhang Y, Wang Y, Lu Q, et al. Bibliometric analysis of mental health during the Covid-19 pandemic. Asian J Psychiatr. (2021) 65:102846. doi: 10.1016/j.ajp.2021.102846

PubMed Abstract | CrossRef Full Text | Google Scholar

53. Akintunde TY, Musa TH, Musa HH, Musa IH, Chen S, Ibrahim E, et al. Bibliometric analysis of global scientific literature on effects of Covid-19 pandemic on mental health. Asian J Psychiatr. (2021) 63:102753. doi: 10.1016/j.ajp.2021.102753

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Pei W, Peng R, Gu Y, Zhou X, Ruan J. Research trends of acupuncture therapy on insomnia in two decades (from 1999 to 2018):a bibliometric analysis. BMC Complement Altern Med. (2019) 19:225. doi: 10.1186/s12906-019-2606-5

PubMed Abstract | CrossRef Full Text | Google Scholar